ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 344

Is Rheumatoid Arthritis a Risk Factor for Fractures: A Systematic Review of Observational Studies

Ambika Gupta1, Stephanie Pipe2, Tanveer Towheed3 and Tassos Anastassiades2, 1Internal Medicine, Queen's University, Kingston, ON, Canada, 2Queen's University, Kingston, ON, Canada, 3Dept of Medicine, Queen's University, Kingston, ON, Canada

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Fracture risk, Osteoporosis and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Osteoporosis and Metabolic Bone Disease – Clinical Aspects and Pathogenesis - Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid Arthritis (RA) is a known risk factor for osteoporosis. There are many factors that contribute to this increased risk, including the use of glucocorticoids, systemic inflammation due to the disease process and relative physical inactivity.  Only a few studies have assessed the risk of fractures in RA. The objective of this systematic review was to assess the risk of fractures in adults with RA compared with controls from the general population.

Methods: Two authors screened citations from the following electronic databases:  MEDLINE (1946 to July 2015), EMBASE (1947 to July 2015), Cochrane Database of Systematic Reviews (2005 to July 2015) and CINAHL (1981 to July 2015). Included citations had to be written in English, only include patients greater than or equal to 18 years of age and compare fracture incidence/prevalence between RA patients and a control group.  Case control, cohort and cross-sectional studies were included. Abstracts and conference proceedings were not searched. The primary outcome was fracture incidence and/or prevalence. Two authors abstracted data using a standardized data abstraction form. The quality of the studies was assessed using the Newcastle-Ottawa Scale (NOS).

Results: The searches resulted in 3451 citations, and after applying the inclusion criteria, we selected seventeen observational studies comparing fracture incidence and/or prevalence between RA and controls. Overall, the results demonstrated that the risk of fracture was elevated in RA compared to controls in 14 of the 17 studies. Thirteen studies were adjusted for glucocorticoid use and there was an increased risk of fracture with glucocorticoid use in 4/13 of these studies. Seven studies analyzed RA severity or functional impairment as a risk factor for fracture and the risk of fracture was elevated in 2/7 of these studies. Fracture ascertainment was performed by searching medical records in seven studies, analyzing spine radiographs in six studies, self-reported history in two studies and by multiple methods in two studies.  Eight studies evaluated fractures at multiple sites, whereas nine studies evaluated fractures only at a single site (spine in 6 and hip in 3).  Only two studies reported specific data on fragility fractures, whereas in the remaining studies, the fracture mechanisms were not defined. Assessment using the NOS revealed that the studies were of high quality. Scoring by NOS criteria revealed that 14/17 studies scored 4/4 on selection, all studies scored 2/2 on comparison and 13/17 studies scored 3/3 on outcome/exposure. Limitations of the studies included the following:  studies enrolled a diverse range of patient and control group populations, and generally included all types of fractures determined by various methods and involving multiple sites. Some studies only included women while others included both genders. The studies took place in different countries. These differences between the studies made it difficult to directly compare them.  Due to the marked study heterogeneity, a meta-analysis was not performed.

Conclusion: The risk of fracture in RA is elevated when compared to the general population.


Disclosure: A. Gupta, None; S. Pipe, None; T. Towheed, None; T. Anastassiades, None.

To cite this abstract in AMA style:

Gupta A, Pipe S, Towheed T, Anastassiades T. Is Rheumatoid Arthritis a Risk Factor for Fractures: A Systematic Review of Observational Studies [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/is-rheumatoid-arthritis-a-risk-factor-for-fractures-a-systematic-review-of-observational-studies/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/is-rheumatoid-arthritis-a-risk-factor-for-fractures-a-systematic-review-of-observational-studies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology